Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 301–400 of 1,020
Jardon, K. M., Canfora, E. E., Goossens, G. H., & Blaak, E. E. (2022) · Gut · doi:10.1136/gutjnl-2020-323715 · Cited by 181
“9 43 44 More consistent, overweight and moderate obesity, IR and T2DM have been associated with compositional changes and decreased microbial richness and diversity when compared with lean, healthy individuals, 41 45–47 and this has been linked to metabolic impairments.”
BackgroundInnate Immune Receptors: Key Regulators of Metabolic Disease Progression
Jin, C., Henao-Mejia, J., & Flavell, R. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.011 · Cited by 189
Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals
Ahmad, A., Yang, W., Chen, G., Shafiq, M., Javed, S., Ali Zaidi, S. S., Shahid, R., Liu, C., & Bokhari, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226372 · Cited by 191
“strong association between the gut microbiota composition and metabolic disorders such as obesity and T2DM [8,9].”
BackgroundRoager, H. M., Licht, T. R., Poulsen, S. K., Larsen, T. M., & Bahl, M. I. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03549-13 · Cited by 194
Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis
Luo, M., Liu, Y., Wu, P., Luo, D.-X., Sun, Q., Zheng, H., Hu, R., Pandol, S. J., Li, Q.-F., Han, Y.-P., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00822 · Cited by 189
“For instance, well established evidence shows that gut microbiome is critical for (1) development of host immune system, (2) harvesting energy from diet, (3) production of vitamin B series, (4) protection against foreign microbe invasion, (5) bile acid turnover, (6) regulation of satiety, (7) and metabolic homeostasis…”
BackgroundInfluentialSynthetic ecology of the human gut microbiota
Vrancken, G., Gregory, A. C., Huys, G. R. B., Faust, K., & Raes, J. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0264-8 · Cited by 193
Kocsis, T., Molnár, B., Németh, D., Hegyi, P., Szakács, Z., Bálint, A., Garami, A., Soós, A., Márta, K., & Solymár, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68440-1 · Cited by 180
Gut microbiota and diet in patients with different glucose tolerance
Egshatyan, L., Kashtanova, D., Popenko, A., Tkacheva, O., Tyakht, A., Alexeev, D., Karamnova, N., Kostryukova, E., Babenko, V., Vakhitova, M., et al. (2016) · Endocrine Connections · doi:10.1530/ec-15-0094 · Cited by 187
Leite, A. Z., Rodrigues, N. D. C., Gonzaga, M. I., Paiolo, J. C. C., de Souza, C. A., Stefanutto, N. A. V., Omori, W. P., Pinheiro, D. G., Brisotti, J. L., Matheucci Junior, E., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01107 · Cited by 185
Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
Salgaço, M. K., Oliveira, L. G. S., Costa, G. N., Bianchi, F., & Sivieri, K. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10156-y · Cited by 182
Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review
Rauf, A., Khalil, A. A., Rahman, U.-U., Khalid, A., Naz, S., Shariati, M. A., Rebezov, M., Urtecho, E. Z., de Albuquerque, R. D. D. G., Anwar, S., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895064 · Cited by 177
Gut microbial dysbiosis in indian children with autism spectrum disorders
Pulikkan, J., Maji, A., Dhakan, D. B., Saxena, R., Mohan, B., Anto, M. M., Agarwal, N., Grace, T., & Sharma, V. K. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1176-2 · Cited by 189
Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides
Zhang, T., Yang, Y., Liang, Y., Jiao, X., & Zhao, C. (2018) · Nutrients · doi:10.3390/nu10081055 · Cited by 184
“Diabetic patients have changed gut microbiota compared with non-diabetic people [71,132].”
BackgroundHsieh, M.-C., Tsai, W.-H., Jheng, Y.-P., Su, S.-L., Wang, S.-Y., Lin, C.-C., Chen, Y.-H., & Chang, W.-W. (2018) · Scientific Reports · doi:10.1038/s41598-018-35014-1 · Cited by 182
The Role of the Gut Microbiota in the Pathogenesis of Diabetes
Bielka, W., Przezak, A., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010480 · Cited by 176
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
“some extent, the impaired barrier function and high LPS level in diabetic subjects [125,126].”
BackgroundIntestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
Zhang, Q., & Hu, N. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s286430 · Cited by 179
“Larsen et al found differences in the gut microbiota at the phylum level between T2DM patients and normal individuals, eg, the non-T2DM group had a significantly higher proportion of Firmicutes than the T2DM group.(10) Two metagenome-wide association studies involving relatively large populations were conducted in Chi…”
ResultBeserra, B. T. S., Fernandes, R., do Rosario, V. A., Mocellin, M. C., Kuntz, M. G. F., & Trindade, E. B. S. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.10.004 · Cited by 182
“and Betaproteobacteria, both of which are highly enriched in diabetic individuals [8].”
BackgroundMethodShepherd, M. L., Swecker, W. S., Jensen, R. V., & Ponder, M. A. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02434.x · Cited by 177
“4%) and pig (35%) using high-throughput sequencing technologies (Larsen et al., 2010; Lamendella et al., 2011).”
BackgroundInfluentialCardiometabolic Benefits of Intermittent Fasting
Varady, K. A., Cienfuegos, S., Ezpeleta, M., & Gabel, K. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-052020-041327 · Cited by 186
Do Interactions Between Gut Ecology and Environmental Chemicals Contribute to Obesity and Diabetes?
Snedeker, S. M., & Hay, A. G. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104204 · Cited by 184
Navarro del Hierro, J., Herrera, T., Fornari, T., Reglero, G., & Martin, D. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.11.032 · Cited by 166
Leaky gut biomarkers in depression and suicidal behavior
Ohlsson, L., Gustafsson, A., Lavant, E., Suneson, K., Brundin, L., Westrin, Å., Ljunggren, L., & Lindqvist, D. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12978 · Cited by 180
“Increased gut permeability and/or dysbiosis have been suggested as pathophysiological mechanisms also in metabolic disorders (18, 44, 45), rheumatoid disorders (46, 47), and HIV infection (25, 48), all conditions with a persistent inflammatory component and a heightened risk of depression (49–52).”
BackgroundDietary fiber and its associations with depression and inflammation
Swann, O. G., Kilpatrick, M., Breslin, M., & Oddy, W. H. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz072 · Cited by 185
Pyrosequencing as a tool for better understanding of human microbiomes
Siqueira, J. F., Fouad, A. F., & Rôças, I. N. (2012) · Journal of Oral Microbiology · doi:10.3402/jom.v4i0.10743 · Cited by 163
“Gut microbiome in diabetics The composition of the gut microbiota in type-2 diabetic individuals was compared to non-diabetic individuals (controls) by a study using pyrosequencing targeting the V4 region of the 16S rRNA gene (74).”
MethodPeriodontitis and implant complications in diabetes
Nibali, L., Gkranias, N., Mainas, G., & Di Pino, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12451 · Cited by 164
Examining the healthy human microbiome concept
Joos, R., Boucher, K., Lavelle, A., Arumugam, M., Blaser, M. J., Claesson, M. J., Clarke, G., Cotter, P. D., De Sordi, L., Dominguez-Bello, M. G., et al. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01107-0 · Cited by 166
“Recent research has shown that the microbiota plays a role in various diseases including autoimmune and inflammatory diseases, cancer, psychiatric disorders, obesity and type 2 diabetes 4–12 .”
Alcohol or gut microbiota: who is the guilty?
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184568 · Cited by 183
“FLASH—Centre of Liver Research Odense, Fyn, Denmark Odense University Hospital Odense, Denmark NCT04014413 07/19–10/24 Not yet recruiting (n = 450) * Interventional Non-Randomized FMT ASH, IBS, T2DM, MetS Investigate the efficacy and safety of FMT in a variety of dysbiosis-associated disorder The Chinese University of…”
BackgroundGut microbiota: A new target for T2DM prevention and treatment
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., & Wei, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958218 · Cited by 176
“Bacteroidetes Firmicutes Betaproteobacteria —— BCAA↑ Insulin-resistant (61, 62)”
Schepper, J. D., Collins, F. L., Rios-Arce, N. D., Raehtz, S., Schaefer, L., Gardinier, J. D., Britton, R. A., Parameswaran, N., & McCabe, L. R. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3635 · Cited by 182
Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns
Del Chierico, F., Abbatini, F., Russo, A., Quagliariello, A., Reddel, S., Capoccia, D., Caccamo, R., Ginanni Corradini, S., Nobili, V., De Peppo, F., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01210 · Cited by 177
“An altered gut microbiota has been observed in obesity and T2D (Larsen et al., 2010; Karlsson et al., 2013; Le Chatelier et al., 2013), and in particular decreased species and gene richness have been linked to adiposity, dyslipidemia, and insulin resistance (Cotillard et al.”
BackgroundGut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia
Picca, A., Fanelli, F., Calvani, R., Mulè, G., Pesce, V., Sisto, A., Pantanelli, C., Bernabei, R., Landi, F., & Marzetti, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/7026198 · Cited by 181
“type 2 diabetes [59, 60], and nonalcoholic steatohepatitis [61] but has also recently been proposed to be involved in nonmetabolic syndromes such as age-related frailty [9], autism [62, 63], Alzheimer’s disease [64], and depression [65].”
BackgroundDas, T., Jayasudha, R., Chakravarthy, S., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., Sharma, S., & Shivaji, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82538-0 · Cited by 179
Assessment and Selection of Competing Models for Zero-Inflated Microbiome Data
Xu, L., Paterson, A. D., Turpin, W., & Xu, W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129606 · Cited by 176
“For example, several studies have revealed the relationships between microbial composition and obesity [3, 4] and type 2 diabetes [5, 6].”
BackgroundDysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.646348 · Cited by 180
The altered gut microbiota in adults with cystic fibrosis
Burke, D. G., Fouhy, F., Harrison, M. J., Rea, M. C., Cotter, P. D., O’Sullivan, O., Stanton, C., Hill, C., Shanahan, F., Plant, B. J., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0968-8 · Cited by 179
Rodes, L. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1205.05018 · Cited by 173
“In addition, substantial evidence has demonstrated that gut dysbiosis [25, 34, 46] might be responsible for increased endotoxemia [37], which further induces chronic low-grade inflammation [5, 33] and participates in the pathophysiology *Corresponding author Phone: +1-514-398-3676; Fax: +1-514-398-7461; E-mail: satya.”
BackgroundUnderstanding the role of gut microbiome in metabolic disease risk
Sanz, Y., Olivares, M., Moya-Pérez, Á., & Agostoni, C. (2015) · Pediatric Research · doi:10.1038/pr.2014.170 · Cited by 174
Prebiotics: Definition and protective mechanisms
Valcheva, R., & Dieleman, L. A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.008 · Cited by 162
Pro-resolving mediators in the regulation of periodontal disease
Van Dyke, T. E. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.006 · Cited by 168
“Pathogens that can persist, particularly intracellular pathogens, can cause significant inflammatory dysregulation (51– 53) and upregulation of systemic inflammation, as in obesity and type 2 diabetes, can cause dysbiosis of the gut microbiome (49).”
BackgroundMediterranean diet and faecal microbiota: a transversal study
Gutiérrez-Díaz, I., Fernández-Navarro, T., Sánchez, B., Margolles, A., & González, S. (2016) · Food & Function · doi:10.1039/c6fo00105j · Cited by 176
The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
Zaky, A., Glastras, S. J., Wong, M. Y. W., Pollock, C. A., & Saad, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179641 · Cited by 172
“The Bacteroidetes to Firmicutes ratio and Bacteroides-Prevotella to Blautia coccoides -Eubacterium rectal were also increased in patients with T2D, and this was shown to positively correlate with plasma glucose levels [95].”
BackgroundBisphenol A alters gut microbiome: Comparative metagenomics analysis
Lai, K.-P., Chung, Y.-T., Li, R., Wan, H.-T., & Wong, C. K.-C. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.08.039 · Cited by 175
“Consistently, growth induction of the family Helicobacteraceae and reduction of the Firmicutes and Clostridia populations were observed in the mice fed BPA or a HFD. Collectively, our study highlighted that the effects of dietary BPA intake on the shift of microbial community structure were similar to those of a HFD a…”
BackgroundInfluentialThe Gut Microbiome and Type 2 Diabetes Mellitus: Discussing A Complex Relationship
Sikalidis, A. K., & Maykish, A. (2020) · Biomedicines · doi:10.3390/biomedicines8010008 · Cited by 170
“Mice were either fed an HFD or HFD supplemented with lipoic acid, an antioxidant known to decrease oxidative stress [61].”
BackgroundMethodGou, W., Ling, C.-W., He, Y., Jiang, Z., Fu, Y., Xu, F., Miao, Z., Sun, T.-Y., Lin, J.-S., Zhu, H.-L., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1536 · Cited by 174
“In addition, we validated the identified MRS–type 2 diabetes relationship in two independent human cohorts and germ-free mice, which has rarely been achieved in prior studies (5,34,35,38).”
MethodResultYang, J., Summanen, P. H., Henning, S. M., Hsu, M., Lam, H., Huang, J., Tseng, C.-H., Dowd, S. E., Finegold, S. M., Heber, D., et al. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00216 · Cited by 168
“The Bacteroidetes/Firmicutes ratio is associated with increased plasma glucose concentrations and a decrease in butyrate-producing bacteria in T2DM patients (Larsen et al., 2010; Shen et al., 2013).”
BackgroundInfluentialGut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
“Compositional sequencing studies have revealed a reduction in the relative proportions of Firmicutes, while Bacteroidetes were enriched in T2D subjects, compared with healthy controls((59)).”
BackgroundReynolds, A. C., Paterson, J. L., Ferguson, S. A., Stanley, D., Wright, K. P., & Dawson, D. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.009 · Cited by 163
Harsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
Murugesan, S., Ulloa-Martínez, M., Martínez-Rojano, H., Galván-Rodríguez, F. M., Miranda-Brito, C., Romano, M. C., Piña-Escobedo, A., Pizano-Zárate, M. L., Hoyo-Vadillo, C., & García-Mena, J. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2355-4 · Cited by 170
“It has been reported that the relative abundance of two phyla, Bacteroidetes and Firmicutes, play a vital role in the development of obesity and type 2 diabetes [42, 43].”
BackgroundLuo, A., Leach, S. T., Barres, R., Hesson, L. B., Grimm, M. C., & Simar, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00417 · Cited by 165
Razmpoosh, E., Javadi, A., Ejtahed, H. S., Mirmiran, P., Javadi, M., & Yousefinejad, A. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.008 · Cited by 167
Fernandes, R., Viana, S. D., Nunes, S., & Reis, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 168
Host mitochondria influence gut microbiome diversity: A role for ROS
Yardeni, T., Tanes, C. E., Bittinger, K., Mattei, L. M., Schaefer, P. M., Singh, L. N., Wu, G. D., Murdock, D. G., & Wallace, D. C. (2019) · Science Signaling · doi:10.1126/scisignal.aaw3159 · Cited by 170
The human gut microbiome and health inequities
Amato, K. R., Arrieta, M.-C., Azad, M. B., Bailey, M. T., Broussard, J. L., Bruggeling, C. E., Claud, E. C., Costello, E. K., Davenport, E. R., Dutilh, B. E., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017947118 · Cited by 165
Enterobacteriaceae in the Human Gut: Dynamics and Ecological Roles in Health and Disease
de Gouveia, M. I. M., Bernalier‐Donadille, A., & Jubelin, G. (2024) · Biology · doi:10.3390/biology13030142 · Cited by 213
Sonestedt, E., Wirfält, E., Wallström, P., Gullberg, B., Orho-Melander, M., & Hedblad, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9589-y · Cited by 171
Robinson, C. M., & Pfeiffer, J. K. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085550 · Cited by 160
Shen, L., Liu, L., & Ji, H.-F. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1361780 · Cited by 161
Liu, F., Prabhakar, M., Ju, J., Long, H., & Zhou, H.-W. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.156 · Cited by 160
Matheus, V., Monteiro, L., Oliveira, R., Maschio, D., & Collares-Buzato, C. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708188 · Cited by 165
Culture independent assessment of human milk microbial community in lactational mastitis
Patel, S. H., Vaidya, Y. H., Patel, R. J., Pandit, R. J., Joshi, C. G., & Kunjadiya, A. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08451-7 · Cited by 163
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X. (2024) · mBio · doi:10.1128/mbio.02032-23 · Cited by 150
“Specifically, the abundance of some butyrate-producing bacteria (such as the phylum Firmicutes and genus Bifidobac terium ) was reduced, while Gram-negative bacteria were relatively enriched such as the phyla Bacteroidetes and Proteobacteria (30, 31).”
BackgroundInfluentialMorita, E., Yokoyama, H., Imai, D., Takeda, R., Ota, A., Kawai, E., Hisada, T., Emoto, M., Suzuki, Y., & Okazaki, K. (2019) · Nutrients · doi:10.3390/nu11040868 · Cited by 169
“The presence of an imbalanced, low-diversity, intestinal microbiota is known as dysbiosis and it is associated with a variety of pathologies, including constipation [1], obesity [2], diabetes [3], colon cancer [4], coronary artery disease [5], inflammatory bowel disease [6], and depression [7].”
BackgroundA tale of two risks: smoking, diabetes and the subgingival microbiome
Ganesan, S. M., Joshi, V., Fellows, M., Dabdoub, S. M., Nagaraja, H. N., O’Donnell, B., Deshpande, N. R., & Kumar, P. S. (2017) · The ISME Journal · doi:10.1038/ismej.2017.73 · Cited by 162
“Although it is known that uncontrolled hyperglycemia similarly increases the risk for periodontitis, very few studies have examined the effects of diabetes on the subgingival microbiome (Zambon et al., 1988; Ciantar et al., 2005; Larsen et al., 2010; Ohlrich et al., 2010; Casarin et al., 2013; Zhou et al., 2013).”
BackgroundVan Dyke, T. E., & Sima, C. (2020) · Periodontology 2000 · doi:10.1111/prd.12317 · Cited by 161
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
Miele, L., Giorgio, V., Alberelli, M. A., De Candia, E., Gasbarrini, A., & Grieco, A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0671-z · Cited by 163
Gut microbiota and probiotics: Focus on diabetes mellitus
Bordalo Tonucci, L., Dos Santos, K. M. O., De Luces Fortes Ferreira, C. L., Ribeiro, S. M. R., De Oliveira, L. L., & Martino, H. S. D. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.934438 · Cited by 164
“Larsen et al. (2010) found a low number of bacteria belonging to the phylum Firmicutes and a high number of Betaproteobacteria in diabetic patients, when compared with those in non-diabetics.”
BackgroundResultInfluentialCo-evolution in context: The importance of studying gut microbiomes in wild animals
Amato, K. R. (2013) · Microbiome Science and Medicine · doi:10.2478/micsm-2013-0002 · Cited by 166
The gut microbiome of nonhuman primates: Lessons in ecology and evolution
Clayton, J. B., Gomez, A., Amato, K., Knights, D., Travis, D. A., Blekhman, R., Knight, R., Leigh, S., Stumpf, R., Wolf, T., et al. (2018) · American Journal of Primatology · doi:10.1002/ajp.22867 · Cited by 162
Fang, W., Xue, H., Chen, X., Chen, K., & Ling, W. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxy324 · Cited by 163
Panwar, H., Rashmi, H. M., Batish, V. K., & Grover, S. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2376 · Cited by 167
Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db/db mice
Chen, C., You, L.-J., Huang, Q., Fu, X., Zhang, B., Liu, R.-H., & Li, C. (2018) · Food & Function · doi:10.1039/c7fo01346a · Cited by 166
Li, H., Fang, Q., Nie, Q., Hu, J., Yang, C., Huang, T., Li, H., & Nie, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01968 · Cited by 163
Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls
Deng, Y., Wang, H., Zhou, J., Mou, Y., Wang, G., & Xiong, X. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-2968 · Cited by 154
“In fact, a similar dysbiosis between Firmicutes and Bacteroidetes in the human gut has been described in previous studies in association with other inflammatory disorders, such as Crohn’s disease and systemic lupus erythematosus (26, 27).”
BackgroundMetabolic Basis for Low Urine pH in Type 2 Diabetes
Maalouf, N. M., Cameron, M. A., Moe, O. W., & Sakhaee, K. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08331109 · Cited by 161
“Alternatively, differences in gut microbiota (20) or longer colonic transit time in patients with type 2 diabetes (21) could lead to more bacterial fermentation of colonic content and secondarily to greater organic anion generation and absorption.”
BackgroundAngelakis, E., & Raoult, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010463 · Cited by 156
“Recently, type 2 diabetes mellitus was associated with compositional changes in the intestinal microbiota, as diabetics presented a significantly lower proportion of Firmicutes and a higher proportion of Bacteroidetes and Proteobacteria [10].”
BackgroundGut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans
Doumatey, A. P., Adeyemo, A., Zhou, J., Lei, L., Adebamowo, S. N., Adebamowo, C., & Rotimi, C. N. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00063 · Cited by 159
The intestinal microbiota in health and disease
Young, V. B. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834d61e9 · Cited by 162
“A number of reports have been published that have looked for associations between the microbiome and various diseases including obesity [19], necrotizing enterocolitis [20], type I and type II diabetes [21,22], irritable bowel syndrome [23,24] and colon cancer [25].”
Backgroundvan den Bogert, B., Meijerink, M., Zoetendal, E. G., Wells, J. M., & Kleerebezem, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114277 · Cited by 162
“Research on this topic has been biased towards the analysis of fecal samples that only provide information about the microbiota at the end of gastrointestinal (GI) tract [13, 14, 15, 16], meaning that, the immune-influences driven by microbial communities in the upper intestinal tract have been largely neglected [17].”
BackgroundPalau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F. J., & Andres-Lacueva, C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01151 · Cited by 157
“In turn, some studies have observed a positive correlation between ratios of Bacteroidetes to Firmicutes and plasma glucose concentration, but not with BMI, although this was expected (Larsen et al., 2010).”
BackgroundChen, Y., Liu, D., Wang, D., Lai, S., Zhong, R., Liu, Y., Yang, C., Liu, B., Sarker, M. R., & Zhao, C. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.034 · Cited by 161
Kumagai, T., Rahman, F., & Smith, A. (2018) · Nutrients · doi:10.3390/nu10101405 · Cited by 161
Dwiyanto, J., Hussain, M. H., Reidpath, D., Ong, K. S., Qasim, A., Lee, S. W. H., Lee, S. M., Foo, S. C., Chong, C. W., & Rahman, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82311-3 · Cited by 161
Lekberg, Y., Schnoor, T. K., Kjøller, R., Gibbons, S. M., Hansen, L. H., Al‐Soud, W. A., Sørensen, S. J., & Rosendahl, S. (2011) · Journal of Ecology · doi:10.1111/j.1365-2745.2011.01894.x · Cited by 160
“All analyses had samples as scaling focus, and all species data were Hellinger-transformed using the program PrCoord 1.0 (Legendre & Gallagher 2001; ter Braak & Šmilauer 2002).”
MethodInfluentialSelf-citationConsidering gut microbiota in treatment of type 2 diabetes mellitus
Adeshirlarijaney, A., & Gewirtz, A. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1717719 · Cited by 177
“Larsen et al.(15) observed differences at the phyla level, namely that ratios of Bacteroidetes:Firmicutes ratio and BacteroidesPrevotella group to Clostridium coccoides– Eubacterium rectale group positively correlated with plasma glucose concentration.”
BackgroundMasoud, W., Takamiya, M., Vogensen, F. K., Lillevang, S., Al-Soud, W. A., Sørensen, S. J., & Jakobsen, M. (2011) · International Dairy Journal · doi:10.1016/j.idairyj.2010.10.007 · Cited by 159
“…has successfully been used to monitor microbial communities in various ecosystems like sputum (Armougom et al., 2009), gut (Andersson et al., 2008; Larsen et al., 2010), soil (Acosta-Martinez, Dowd, Sun, & Allen, 2008), wounds (Dowd et al., 2008) and fermented foods (Humblot & Guyot, 2009; Roh et…”
MethodSelf-citationUnderstanding the role of the gut ecosystem in diabetes mellitus
Aw, W., & Fukuda, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12673 · Cited by 172
“Larsen et al.(49) noted that in human male type 2 diabetes patients, as compared with non-diabetic healthy subjects, there were significantly fewer Firmicutes, including Clostridia.”
Letchumanan, G., Abdullah, N., Marlini, M., Baharom, N., Lawley, B., Omar, M. R., Mohideen, F. B. S., Addnan, F. H., Fariha, M. M. N., Ismail, Z., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943427 · Cited by 171
Jensen, A., Fagö-Olsen, H., Sørensen, C. H., & Kilian, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056418 · Cited by 173
Xu, X., Gao, Z., Yang, F., Yang, Y., Chen, L., Han, L., Zhao, N., Xu, J., Wang, X., Ma, Y., et al. (2020) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.09.007 · Cited by 156
“Recent studies have shown that gut microbiota plays an increasingly important role in the development and treatment of T2DM [4,11,15,17,36–38].”
Gut microbiome and metabolic diseases
Fukuda, S., & Ohno, H. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0399-z · Cited by 170
“[58] found that the gut microbiota of human male subjects with type 2 diabetes had significantly fewer Firmicutes, including Clostridia, than that of non-diabetic control subjects.”
BackgroundDirect sequencing of the human microbiome readily reveals community differences
Kuczynski, J., Costello, E. K., Nemergut, D. R., Zaneveld, J., Lauber, C. L., Knights, D., Koren, O., Fierer, N., Kelley, S. T., Ley, R. E., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-210 · Cited by 160
The impact of diabetes on corneal nerve morphology and ocular surface integrity
Markoulli, M. P., Flanagan, J., Tummanapalli, S. S., Wu, J., & Willcox, M. D. P. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.10.006 · Cited by 169
Effects of polysaccharides on glycometabolism based on gut microbiota alteration
Fang, Q., Hu, J., Nie, Q., & Nie, S. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.08.015 · Cited by 158
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 152
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Wang, Y.-C., Koay, Y. C., Pan, C., Zhou, Z., Tang, W. H. W., Wilcox, J. D., Li, X. S., Zagouras, A. A., Marques, F. Z., Allayee, H., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.322381 · Cited by 165
“43,44 47 Our data indicate that IPA appears to be acting in the heart by at least 2 pathways.”
BackgroundTransfer of gut microbiota from lean and obese mice to antibiotic-treated mice
Ellekilde, M., Selfjord, E., Larsen, C. S., Jakesevic, M., Rune, I., Tranberg, B., Vogensen, F. K., Nielsen, D. S., Bahl, M. I., Licht, T. R., et al. (2014) · Scientific Reports · doi:10.1038/srep05922 · Cited by 153
Self-citationThe human gut microbiome, a taxonomic conundrum
Sankar, S. A., Lagier, J., Pontarotti, P., Raoult, D., & Fournier, P. (2015) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2015.03.004 · Cited by 182
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.